Profile data is unavailable for this security.
About the company
Bio-Thera Solutions Ltd is a China-based company primarily engaged in the research and development of innovative drugs and biosimilars. The Company’s main products include QLETLI (adalimumab), POBEVCY (bevacizumab), TOFIDENCE (tocilizumab), BETAGRIN (bevifibatide citrate) and other products. The Company’s products are mainly used for the treatment of cancer, autoimmune diseases, cardiovascular diseases, ophthalmic conditions, and other illnesses. The Company conducts its business in the domestic and overseas markets.
- Revenue in CNY (TTM)845.32m
- Net income in CNY-368.84m
- Incorporated2003
- Employees1.17k
- LocationBio-Thera Solutions LtdNo. 18 Spiral 2nd RoadInternational Bio IslandGUANGZHOU 510005ChinaCHN
- Phone+86 2 032203528
- Fax+86 2 032203218
- Websitehttps://www.bio-thera.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Aladdin Biochemical Tech Co Ltd | 599.98m | 83.95m | 5.33bn | 652.00 | 64.42 | 4.99 | -- | 8.88 | 0.2485 | 0.2485 | 1.78 | 3.21 | 0.2785 | 0.4218 | 4.55 | 920,216.30 | 5.04 | 7.81 | 6.90 | 8.60 | 62.21 | 60.61 | 18.09 | 24.95 | 1.53 | 9.15 | 0.3541 | 48.33 | 32.44 | 20.55 | 15.07 | 9.17 | 41.61 | -- |
| Hangzhou Alltest Biotech Co Ltd | 881.63m | 294.76m | 5.48bn | 969.00 | 18.55 | 1.40 | -- | 6.21 | 3.72 | 3.72 | 11.12 | 49.21 | 0.2098 | 2.38 | 6.39 | 909,839.10 | 7.02 | 19.18 | 7.57 | 21.66 | 55.00 | 57.79 | 33.47 | 38.82 | 8.34 | -- | 0.0093 | 35.14 | 14.83 | 29.13 | 67.50 | 30.99 | 71.01 | -- |
| Bide Pharmatech Co Ltd | 1.27bn | 153.31m | 5.49bn | 738.00 | 34.35 | 2.74 | -- | 4.32 | 1.76 | 1.76 | 14.49 | 22.03 | 0.5167 | 0.8804 | 5.25 | 1,720,520.00 | 6.24 | 7.02 | 7.52 | 8.29 | 43.30 | 42.16 | 12.07 | 13.13 | 2.78 | -- | 0.1055 | 48.73 | 0.9298 | 34.69 | 7.17 | -- | 80.65 | -- |
| Shouyao Holdings Co Ltd | 2.14m | -206.73m | 6.04bn | 178.00 | -- | 9.23 | -- | 2,818.82 | -1.39 | -1.39 | 0.0144 | 4.40 | 0.0025 | 0.0366 | 0.2625 | 12,033.88 | -23.67 | -32.53 | -27.20 | -36.25 | 95.74 | 99.43 | -9,651.03 | -3,370.01 | 6.42 | -- | 0.0044 | -- | -24.61 | -19.34 | -14.21 | -- | 49.71 | -- |
| Jiangsu Yahong Meditech Co Ltd | 279.02m | -362.17m | 6.93bn | 391.00 | -- | 3.91 | -- | 24.83 | -0.642 | -0.642 | 0.4933 | 3.10 | 0.125 | 11.16 | 4.19 | 713,603.90 | -16.84 | -14.30 | -19.15 | -15.01 | 72.22 | 73.78 | -134.65 | -703.80 | 4.96 | -- | 0.1545 | -- | 1,365.55 | -- | 4.09 | -- | 50.48 | -- |
| GemPharmatech Co Ltd | 752.70m | 121.51m | 7.22bn | 1.58k | 58.57 | 3.28 | -- | 9.59 | 0.3007 | 0.3007 | 1.86 | 5.37 | 0.2807 | 4.51 | 1.88 | 476,993.40 | 4.53 | 7.69 | 5.42 | 8.96 | 61.84 | 68.17 | 16.14 | 25.58 | 3.17 | -- | 0.1295 | 21.94 | 10.39 | 28.94 | -30.89 | 25.88 | 20.02 | -- |
| Beijing Sun-Novo Pharma Research Co Ltd | 1.02bn | 133.01m | 7.73bn | 1.36k | 56.81 | 6.65 | -- | 7.59 | 1.21 | 1.21 | 9.23 | 10.38 | 0.4745 | 35.48 | 1.28 | 653,956.40 | 6.04 | 11.39 | 10.49 | 18.82 | 48.60 | 53.31 | 12.72 | 19.66 | 1.78 | 9.97 | 0.3355 | 11.29 | 15.70 | 35.80 | -3.98 | 30.21 | 3.50 | -- |
| Shanghai Medicilon Inc | 1.08bn | -231.86m | 9.16bn | 2.27k | -- | 4.44 | -- | 8.49 | -1.75 | -1.75 | 8.04 | 15.36 | 0.3759 | 8.56 | 1.68 | 459,338.00 | -8.08 | 3.66 | -9.99 | 4.63 | 16.27 | 31.15 | -21.49 | 6.67 | 2.19 | -- | 0.1508 | 40.97 | -24.01 | 18.22 | -896.21 | -- | 2.54 | -- |
| Bio-Thera Solutions Ltd | 845.32m | -368.84m | 10.05bn | 1.17k | -- | 20.75 | -- | 11.88 | -0.8908 | -0.8908 | 2.04 | 1.17 | 0.3702 | 0.7722 | 5.96 | -- | -16.15 | -16.38 | -33.76 | -22.22 | 74.99 | 77.05 | -43.63 | -62.11 | 0.4617 | -34.12 | 0.573 | -- | 5.44 | 302.90 | -29.34 | -- | 11.14 | -- |
| HitGen Inc | 498.51m | 114.11m | 12.12bn | 483.00 | 107.14 | 8.24 | -- | 24.31 | 0.2824 | 0.2824 | 1.24 | 3.67 | 0.2726 | 6.37 | 4.69 | 1,032,114.00 | 6.18 | 3.06 | 6.87 | 3.36 | 55.23 | 53.55 | 22.67 | 14.48 | 5.12 | 6.59 | 0.1674 | 34.32 | 14.99 | 10.08 | 26.13 | -15.65 | 3.16 | -- |
| InventisBio Co Ltd | 180.53m | -116.28m | 13.55bn | 185.00 | -- | 8.14 | -- | 75.06 | -0.2012 | -0.2012 | 0.3122 | 2.88 | 0.0988 | -- | 1.03 | 975,824.70 | -6.36 | -32.89 | -6.76 | -35.22 | 99.41 | -- | -64.41 | -682.73 | -- | -- | 0.0127 | -- | -9.02 | 25.00 | 15.41 | -- | -3.97 | -- |
Data as of Feb 11 2026. Currency figures normalised to Bio-Thera Solutions Ltd's reporting currency: Chinese Yuan Renminbi CNY
3.14%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 5.09m | 1.24% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 1.40m | 0.34% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 1.33m | 0.32% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 1.06m | 0.26% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 960.35k | 0.24% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 940.92k | 0.23% |
| Chang Xin Asset Management Co., Ltd.as of 30 Jun 2025 | 591.38k | 0.15% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 550.51k | 0.14% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2025 | 482.49k | 0.12% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2025 | 445.04k | 0.11% |
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
